Gao, X., et al., Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
Liraglutide has been tested in two trials in people with HF and reduced LV EF
A week without scale movement sends some users searching for answers when the only real answer is patience
Discussion should cover injection technique, adverse effect management, cost considerations (often $900-1,300 monthly without insurance coverage), and long-term treatment duration, as weight regain commonly occurs after discontinuation
Zu den praktischen Risiken bei injizierbaren Formen gehren lokale Reaktionen wie Rtungen, Schwellungen oder Blutergsse an der Einstichstelle sowie das Infektionsrisiko bei nicht sterilem Arbeiten